Published 2 months ago • loading... • Updated 2 months ago

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

(MedPage Today) -- Shanghai-based biotech company HuidaGene Therapeutics disclosed the death of a child 1 year ago in a trial of an investigational gene-editing therapy for Duchenne muscular dystrophy. Semaglutide (Wegovy) attenuated a proteomics...

1 Articles

MedPage Today

Center

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

2 months ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Coverage Details

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated2 months agoBias Distribution

100% Center

Bias Distribution

100% of the sources are Center

100% Center

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

MedPage Today broke the news in New York, United States 2 months ago on Tuesday, August 11, 2026.

Sources are mostly out of (0)

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

1 Articles

1 Articles

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Canadian Newsrooms Confront AI Personas Repurposing Stories Across 100 Cities

More and more young children now taking GLP-1 drugs for weight loss

Drugs, Impact of Glp-1 Therapies: in Milan The Metabolic Frontier

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

Critics say GLP-1 coverage shift raises equity issues

Postpartum GLP-1 Prescriptions Rise Sharply Among U.S. Women

Similar News Topics

Similar News Topics

More stories like this

Canadian Newsrooms Confront AI Personas Repurposing Stories Across 100 Cities

More and more young children now taking GLP-1 drugs for weight loss

Drugs, Impact of Glp-1 Therapies: in Milan The Metabolic Frontier

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

Critics say GLP-1 coverage shift raises equity issues

Postpartum GLP-1 Prescriptions Rise Sharply Among U.S. Women

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

1 Articles

1 Articles

Child Dies in Gene-Editing Trial; Wegovy & Dementia Score; RFK Jr. Questions Journal

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Canadian Newsrooms Confront AI Personas Repurposing Stories Across 100 Cities

More and more young children now taking GLP-1 drugs for weight loss

Drugs, Impact of Glp-1 Therapies: in Milan The Metabolic Frontier

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

Critics say GLP-1 coverage shift raises equity issues

Postpartum GLP-1 Prescriptions Rise Sharply Among U.S. Women

Similar News Topics

Similar News Topics

More stories like this

Canadian Newsrooms Confront AI Personas Repurposing Stories Across 100 Cities

More and more young children now taking GLP-1 drugs for weight loss

Drugs, Impact of Glp-1 Therapies: in Milan The Metabolic Frontier

Eli Lilly's experimental weight loss drug shed 21% of body weight in diabetes trial

Critics say GLP-1 coverage shift raises equity issues

Postpartum GLP-1 Prescriptions Rise Sharply Among U.S. Women

Bias Distribution

Factuality